Association between Early Treatment and Favorable Clinical Outcomes of COVID-19: Evidence from Nine Provinces in China
Association (psychology)
2019-20 coronavirus outbreak
DOI:
10.2139/ssrn.3619794
Publication Date:
2020-07-31T11:41:06Z
AUTHORS (90)
ABSTRACT
Background: Few studies have examined the association between treatment given time and clinical outcomes, which is indeed of great importance to management coronavirus disease 2019 (COVID-19). We performed this study explore whether early brings favorable outcomes. Methods: In retrospective multicenter study, we included patients aged 18 87 years with confirmed COVID-19 on admission from 54 hospitals in nine provinces China 21 January 10 March, 2020. Final date follow-up was March 17, All were treated by Lung cleansing & detoxifying decoction combined western medicine. Patients divided into four groups according interval first onset symptoms starting a treatment, i.e., ≤1 week group (≤7 days), 1-2 weeks (>7 days ≤14 2-3 (>14 ≤21 days) >3 (>21 days). Multivariable Cox proportional hazard ratio (HR) models used estimate unadjusted adjusted HRs 95% confidence intervals (CIs) for outcomes (time recovery, viral shedding, duration hospital stay, course disease, fever CT images). Findings: Of 782 (median age 46 old, 405 (52%) male), there 321 (41%) group, 221 (28%) 123 (16%) 117 (15%) group. Compared later (greater than 3 weeks), earlier less 1 week, 2 weeks, or had higher likelihood HR (95% CI) 3.81 (2.65-5.48), 2.63 (1.86-3.73) 1.92 (1.34-2.75), respectively. The median shedding 13 12 <2 respectively, shorter that (P=0.0137). decreased 34 24 days, when every one advance compared (P<0.0001). Treatment within since related decrease 4 terms stay Interpretation: Earlier associated including sooner stay. This paper demonstrated could be an effective strategy epidemic control, can provide evidence government international organizations develop policy COVID-19.Funding Statement: supported "National Science Technology Major Project" (2018ZX10101001-005-003, 2018ZX10101001-005-004).Declaration Interests: authors declare no competing interests.Ethics Approval approved National Administration Traditional Chinese Medicine, Medicine institutional board participating setting. Due urgency COVID-19, requirement informed consent participants replaced verbal consent.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....